Literature DB >> 14648445

High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina.

Mercedes Weissenbacher1, Diana Rossi, Graciela Radulich, Sergio Sosa-Estáni, Marcelo Vila, Enrique Vivas, María M Avila, Paloma Cuchi, Jorge Rey, Liliana Martínez Peralta.   

Abstract

Injection drug use is the main mechanism of human immunodeficiency virus (HIV) transmission in Argentina (40% of reported AIDS cases in Argentina). This study was conducted among street-recruited injection drug users (IDUs) from Buenos Aires, with the aim of estimating seroprevalence and coinfection of HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and human T-lymphotropic viruses (HTLVs). A total of 174 volunteers participated in this study; 137 were men (78.7% of volunteers). The average age of the participants was 30 years. Only 64 of participants (37%) had no viral infection, whereas 110 (63%) were infected with > or =1 viruses. Seroprevalences were 44.3% for HIV, 54.6% for HCV, 42.5% for HBV, 2.3% for HTLV-I, and 14.5% for HTLV-II. Among the 77 HIV-infected persons, only 6.5% (5 persons) were not coinfected with other viruses; 88.3% (68) were coinfected with HCV and 68.8% (53) were coinfected with HBV. We demonstrated the existence of multiple viral infections with a high rate of prevalence in IDUs in Buenos Aires, Argentina.

Entities:  

Mesh:

Year:  2003        PMID: 14648445     DOI: 10.1086/377560

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.

Authors:  Samuel R Friedman; Wouter de Jong; Diana Rossi; Graciela Touzé; Russell Rockwell; Don C Des Jarlais; Richard Elovich
Journal:  Int J Drug Policy       Date:  2006-12-28

2.  Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project.

Authors:  M A Pando; M Gómez-Carrillo; M Vignoles; A E Rubio; M S dos Ramos Farias; M Vila; D Rossi; G Ralón; R Marone; E Reynaga; J Sosa; O Torres; M Maestri; M M Avila; H Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-23       Impact factor: 2.205

3.  Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users.

Authors:  Jianrong Li; Jing Wang; Kunlun Tian; Yixin Wang; Lei Zhang; Hanju Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients.

Authors:  W Jay Christian; Claudia Hopenhayn; Amy Christian; Deana McIntosh; Alvaro Koch
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

5.  Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.

Authors:  Juan C Reyes; Héctor M Colón; Rafael R Robles; Eddy Rios; Tomás D Matos; Juan Negrón; Carmen Amalia Marrero; José M Calderón; Elizabeth Shepard
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

6.  Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B.

Authors:  Gavin Bart; Paola Piccolo; Linqi Zhang; Ira Jacobson; Robert A Schaefer; Mary Jeanne Kreek
Journal:  Addiction       Date:  2008-04       Impact factor: 6.526

7.  Determinants of treatment access in a population-based cohort of HIV-positive men and women living in Argentina.

Authors:  Carlos Zala; Clare A Rustad; Keith Chan; Nabeela I Khan; Marcelo Beltran; Eduardo Warley; Mariana Ceriotto; Eric F Druyts; Robert S Hogg; Julio Montaner; Pedro Cahn
Journal:  Medscape J Med       Date:  2008-04-02

8.  Prevalence of hepatitis C virus infection according to the year of birth: identification of risk groups.

Authors:  K Neukam; E Ridruejo; P Pérez; R H Campos; A P Martínez; F A Di Lello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-27       Impact factor: 3.267

9.  Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina.

Authors:  Carlos Zala; Clare A Rustad; Keith Chan; Nabeela I Khan; Marcelo Beltran; Eduardo Warley; Mariana Ceriotto; Eric F Druyts; Robert S Hogg; Julio Montaner; Pedro Cahn
Journal:  J Int AIDS Soc       Date:  2008-04-02       Impact factor: 5.396

Review 10.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.